FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulrich Herrlinger

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Living Beings

Rats
Mouse

Anatomy

Brain

Co-author Network

Publications

TOP 3
Eckhard Thiel; Agnieszka Korfel; Peter Martus; Lothar Kanz; Frank Griesinger; Michael Rauch; Alexander Röth; Bernd Hertenstein; Theda von Toll; Thomas Hundsberger; Hans-Günther Mergenthaler; Malte Leithäuser; Tobias Birnbaum; Lars Fischer; Kristoph Jahnke; Ulrich Herrlinger; Ludwig Plasswilm; Thomas Nägele; Torsten Pietsch; D D; Michael Weller
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Markus Weiler; Christian Hartmann; Dorothee Wiewrodt; Ulrich Herrlinger; Thierry Gorlia; Oliver Bähr; Richard Meyermann; D D; Marcos Tatagiba; Andreas von Deimling; Michael Weller; Wolfgang Wick
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.
S A Grimm; C A McCannel; Antonio M P Omuro; Andrés J M Ferreri; J-Y Blay; Edward A Neuwelt; Tali Siegal; Tracy T Batchelor; Kristoph Jahnke; Tamara N Shenkier; A J Hall; Francesc Graus; Ulrich Herrlinger; David Schiff; Jeffrey J Raizer; J Rubenstein; Normand Laperriere; Eckhard Thiel; Nancy D Doolittle; Fabio M Iwamoto; Lauren E Abrey
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulrich Herrlinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Eckhard Thiel; Agnieszka Korfel; Peter Martus; Lothar Kanz; Frank Griesinger; Michael Rauch; Alexander Röth; Bernd Hertenstein; Theda von Toll; Thomas Hundsberger; Hans-Günther Mergenthaler; Malte Leithäuser; Tobias Birnbaum; Lars Fischer; Kristoph Jahnke; Ulrich Herrlinger; Ludwig Plasswilm; Thomas Nägele; Torsten Pietsch; D D; Michael Weller
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
The lancet oncology 2010;11(11):1036-47.
2010: Markus Weiler; Christian Hartmann; Dorothee Wiewrodt; Ulrich Herrlinger; Thierry Gorlia; Oliver Bähr; Richard Meyermann; D D; Marcos Tatagiba; Andreas von Deimling; Michael Weller; Wolfgang Wick
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.
International journal of radiation oncology, biology, physics 2010;77(3):670-6.
2008: S A Grimm; C A McCannel; Antonio M P Omuro; Andrés J M Ferreri; J-Y Blay; Edward A Neuwelt; Tali Siegal; Tracy T Batchelor; Kristoph Jahnke; Tamara N Shenkier; A J Hall; Francesc Graus; Ulrich Herrlinger; David Schiff; Jeffrey J Raizer; J Rubenstein; Normand Laperriere; Eckhard Thiel; Nancy D Doolittle; Fabio M Iwamoto; Lauren E Abrey
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
Neurology 2008;71(17):1355-60.
2008: Martin Glas; Burkhard Hennemann; Birgit Hirschmann; Jörg Marienhagen; Ingo Schmidt-Wolf; Ulrich Herrlinger; Ulrich Bogdahn; Peter Hau
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Acta oncologica (Stockholm, Sweden) 2008;47(3):479-80.
2007: S A Grimm; J S Pulido; Kristoph Jahnke; David Schiff; A J Hall; Tamara N Shenkier; Tali Siegal; Nancy D Doolittle; Tracy T Batchelor; Ulrich Herrlinger; Edward A Neuwelt; Normand Laperriere; M C Chamberlain; J Y Blay; Andrés J M Ferreri; Antonio M P Omuro; Eckhard Thiel; Lauren E Abrey
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1851-5.
2007: Antje Wick; Jörg Felsberg; Joachim P Steinbach; Ulrich Herrlinger; Michael Platten; Britta Blaschke; Richard Meyermann; Guido Reifenberger; Michael Weller; Wolfgang Wick
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3357-61.
2007: Andreas H Jacobs; Maria Adele Rueger; Alexandra Winkeler; Hongfeng Li; Stefan Vollmar; Yannic Waerzeggers; Benedikt Rueckriem; Christiane Kummer; Claus Dittmar; Markus Klein; Michael T Heneka; Ulrich Herrlinger; Cornel Fraefel; Rudolf Graf; Klaus Wienhard; Wolf-Dieter Heiss
Imaging-guided gene therapy of experimental gliomas.
Cancer research 2007;67(4):1706-15.
2007: Martin Glas; Horst Koch; Birgit Hirschmann; Tanya Jauch; Andreas Steinbrecher; Ulrich Herrlinger; Ulrich Bogdahn; Peter Hau
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.
Oncology 2007;72(5-6):302-7.
2006: Kristoph Jahnke; Eckhard Thiel; Peter Martus; Ulrich Herrlinger; Michael Weller; Lars Fischer; Agnieszka Korfel
Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.
Journal of neuro-oncology 2006;80(2):159-65.
2006: Ulrich Herrlinger; Johannes Rieger; Dorothee Koch; Simon Loeser; Britta Blaschke; Rolf-Dieter Kortmann; Joachim P Steinbach; Thomas Hundsberger; Wolfgang Wick; Richard Meyermann; Ta-Chih Tan; Clemens Sommer; D D; Guido Reifenberger; Michael Weller
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(27):4412-7.
2006: Wilhelm Küker; Irina Mader; Thomas Nägele; M Uhl; C Adolph; Uwe Klose; Ulrich Herrlinger
Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(8):819-26.
2006: Kristoph Jahnke; Agnieszka Korfel; Brian Patrick O'Neill; Jean-Yves Blay; Lauren E Abrey; Peter Martus; Philip Poortmans; Tamara N Shenkier; Tracy T Batchelor; Edward A Neuwelt; Jeffrey J Raizer; David Schiff; Hendrik Pels; Ulrich Herrlinger; Harald Stein; Eckhard Thiel
International study on low-grade primary central nervous system lymphoma.
Annals of neurology 2006;59(5):755-62.
2006: Gernot Stuhler; Stefan Knop; M S Topp; Stefan Kröber; Ulrike Ernemann; Ulrich Herrlinger; Hermann Einsele; Lothar Kanz; Holger Hebart
Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantation.
Haematologica 2006;91(3):ECR01.
2006: F Schmidt; J Fischer; Ulrich Herrlinger; K Dietz; Johannes Dichgans; Michael Weller
PCV chemotherapy for recurrent glioblastoma.
Neurology 2006;66(4):587-9.
2006: Joachim P Steinbach; H-P Blaicher; Ulrich Herrlinger; Wolfgang Wick; Thomas Nägele; Richard Meyermann; M Tatagiba; D D; Johannes Dichgans; Hans-Otto Karnath; Michael Weller
Surviving glioblastoma for more than 5 years: the patient's perspective.
Neurology 2006;66(2):239-42.
2005: Stefan Knop; Ulrich Herrlinger; Ulrike Ernemann; Lothar Kanz; Holger Hebart
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.
Leukemia & lymphoma 2005;46(11):1593-8.
2005: Wilhelm Küker; Thomas Nägele; E Thiel; Michael Weller; Ulrich Herrlinger
Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Neurology 2005;65(7):1129-31.
2005: Ulrich Herrlinger; Wilhelm Küker; Martin Uhl; Hans-Peter Blaicher; Hans-Otto Karnath; Lothar Kanz; D D; Michael Weller
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
Annals of neurology 2005;57(6):843-7.
2005: Wilhelm Küker; P Bader; Ulrich Herrlinger; Stefan Heckl; Thomas Nägele
Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Journal of neuro-oncology 2005;73(1):47-9.
2005: Wilhelm Küker; Thomas Nägele; Agnieszka Korfel; Stefan Heckl; Eckhard Thiel; D D; Michael Weller; Ulrich Herrlinger
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.
Journal of neuro-oncology 2005;72(2):169-77.
2005: Martin Uhl; Markus Weiler; Wolfgang Wick; Andreas H Jacobs; Michael Weller; Ulrich Herrlinger
Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.
Biochemical and biophysical research communications 2005;328(1):125-9.
2005: Ulrich Herrlinger; Andreas Steinbrecher; J Rieger; Peter Hau; Rolf-Dieter Kortmann; Richard Meyermann; Martin Schabet; D D; Johannes Dichgans; Ulrich Bogdahn; Michael Weller
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Journal of neurology 2005;252(3):291-9.
2005: Kristoph Jahnke; Eckhard Thiel; Andreas Schilling; Ulrich Herrlinger; Michael Weller; Sarah E Coupland; Ulrich Krümpelmann; Harald Stein; Agnieszka Korfel
Low-grade primary central nervous system lymphoma in immunocompetent patients.
British journal of haematology 2005;128(5):616-24.
2005: Kristoph Jahnke; Agnieszka Korfel; Peter Martus; Michael Weller; Ulrich Herrlinger; Alexander Schmittel; Lars Fischer; Eckhard Thiel
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):445-9.
2005: Ulrich Herrlinger; Johannes Rieger; Joachim P Steinbach; Thomas Nägele; Johannes Dichgans; Michael Weller
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.
Journal of neuro-oncology 2005;71(3):295-9.
2005: Ulrich Herrlinger; Agnieszka Korfel; Holger Hebart; Uwe Schlegel; Ludwig Plasswilm; Gerald Illerhaus; Jürgen Finke; William Krüger; Michael Montemurro; Timo Wolf; Eckhart Thiel; D D; Michael Weller; Lothar Kanz
Meeting report: primary central nervous system lymphoma: standards of care and future perspectives.
Onkologie 2005;28(2):109-11.
2005: Heinz Wiendl; Robert Weissert; Ulrich Herrlinger; Hilmar Krapf; Wilhelm Küker
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
European neurology 2005;53(1):42-4.
2004: Wilhelm Küker; Friederike Schmidt; Stefan Heckl; Thomas Nägele; Ulrich Herrlinger
Bilateral Wallerian degeneration of the middle cerebellar peduncles due to paramedian pontine infarction: MRI findings.
Neuroradiology 2004;46(11):896-9.
2004: Martin Uhl; Steffen Aulwurm; Jörg Wischhusen; Markus Weiler; Jing Ying Ma; Ramona Almirez; Ruban Mangadu; Yu-Wang Liu; Michael Platten; Ulrich Herrlinger; Alison Murphy; Darren H Wong; Wolfgang Wick; Linda S Higgins; Michael Weller
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Cancer research 2004;64(21):7954-61.
2004: Ulrich Herrlinger; Heike Förschler; Wilhelm Küker; Richard Meyermann; D D; Johannes Dichgans; Michael Weller
Leptomeningeal metastasis: survival and prognostic factors in 155 patients.
Journal of the neurological sciences 2004;223(2):167-78.
2004: Ulrich Herrlinger; Heinz Wiendl; M Renninger; H Förschler; Johannes Dichgans; Michael Weller
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.
British journal of cancer 2004;91(2):219-24.
2004: Wilhelm Küker; Thomas Nägele; Friederike Schmidt; Stefan Heckl; Ulrich Herrlinger
Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases.
Neuroradiology 2004;46(2):122-5.
2004: Ulrich Herrlinger; Steffen Aulwurm; Herwig M Strik; Simone Weit; Ulrike Naumann; Michael Weller
MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.
Journal of neuro-oncology 2004;66(1-2):147-54.
2003: Irina Mader; Ulrich Herrlinger; Uwe Klose; Friederike Schmidt; Wilhelm Küker
Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.
Neuroradiology 2003;45(10):717-21.
2003: Andreas Hillemanns; Rolf-Dieter Kortmann; Ulrich Herrlinger; Martin Skalej; Hilmar Krapf
Recurrent delayed brain hemorrhage over years after irradiation and chemotherapy for astrocytoma.
European radiology 2003;13(8):1891-4.
2002: Wilhelm Küker; Ulrich Herrlinger; Eckehard Grönewäller; J M Rohrbach; Michael Weller
Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
Journal of neurology 2002;249(12):1713-6.
2002: Ulrich Herrlinger; Jörg Felsberg; Wilhelm Küker; Antje Bornemann; Ludwig Plasswilm; Christiane B Knobbe; Herwig M Strik; Wolfgang Wick; Richard Meyermann; Johannes Dichgans; D D; Guido Reifenberger; Michael Weller
Gliomatosis cerebri: molecular pathology and clinical course.
Annals of neurology 2002;52(4):390-9.
2002: Ludwig Plasswilm; Ulrich Herrlinger; Agnieszka Korfel; Michael Weller; Wilhelm Küker; Lothar Kanz; E Thiel; D D
Primary central nervous system (CNS) lymphoma in immunocompetent patients.
Annals of hematology 2002;81(8):415-23.
2002: Ulrich Herrlinger; Wilhelm Küker; Michael Platten; Johannes Dichgans; Michael Weller
First-line therapy with temozolomide induces regression of primary CNS lymphoma.
Neurology 2002;58(10):1573-4.
2002: Ulrich Herrlinger; M Weller; Wilhelm Küker
Primary CNS lymphoma in the spinal cord: clinical manifestations may precede MRI detectability.
Neuroradiology 2002;44(3):239-44.
2002: Ulrich Herrlinger; Martin Schabet; Wolfram Brugger; Rolf-Dieter Kortmann; Wilhelm Küker; Martina Deckert; Corinna Engel; Hans-Jürgen Schmeck-Lindenau; Hans-Günther Mergenthaler; Peter Krauseneck; Christian Benöhr; Christoph Meisner; Otmar D Wiestler; Johannes Dichgans; Lothar Kanz; D D; Michael Weller
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
Annals of neurology 2002;51(2):247-52.
2001: Udo Bühring; Ulrich Herrlinger; T Krings; R Thiex; Michael Weller; Wilhelm Küker
MRI features of primary central nervous system lymphomas at presentation.
Neurology 2001;57(3):393-6.
2001: A Jacobs; Juri Gelovani Tjuvajev; M Dubrovin; Timothy Akhurst; Julius Balatoni; Bradley Beattie; R Joshi; Ronald Finn; Steven M Larson; Ulrich Herrlinger; Peter Pechan; E Antonio Chiocca; Xandra O Breakefield; Ronald Blasberg
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Cancer research 2001;61(7):2983-95.
2001: Ulrich Herrlinger; Martin Schabet; Wolfram Brugger; Rolf-Dieter Kortmann; Lothar Kanz; D D; Johannes Dichgans; Michael Weller
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
Cancer 2001;91(1):130-5.
2000: Karen S Aboody; A Brown; Nikolai G Rainov; K A Bower; S Liu; W Yang; J E Small; Ulrich Herrlinger; Václav Ourednik; Peter Black; Xandra O Breakefield; Evan Y Snyder
Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(23):12846-51.
2000: F Schmidt; Wolfgang Wick; Ulrich Herrlinger; Johannes Dichgans; Michael Weller
Treosulfan chemotherapy for recurrent malignant glioma.
Journal of neuro-oncology 2000;49(3):231-4.
2000: Ulrich Herrlinger; Peter Pechan; Andreas H Jacobs; C Woiciechowski; Nikolai G Rainov; Cornel Fraefel; W Paulus; Steven A Reeves
HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
The journal of gene medicine 2000;2(5):379-89.
2000: Ulrich Herrlinger; A Jacobs; Ariel Quinones; C Woiciechowsky; Miguel Sena-Esteves; Nikolai G Rainov; Cornel Fraefel; Xandra O Breakefield
Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Human gene therapy 2000;11(10):1429-38.
2000: Ulrich Herrlinger; K Klingel; Richard Meyermann; Reinhard Kandolf; Edwin Kaiserling; Rolf-Dieter Kortmann; Arthur Melms; Martin Skalej; Johannes Dichgans; Michael Weller
Central nervous system Hodgkin's lymphoma without systemic manifestation: case report and review of the literature.
Acta neuropathologica 2000;99(6):709-14.
2000: Ulrich Herrlinger; Wolfram Brugger; D D; Wilhelm Küker; Johannes Dichgans; Michael Weller
PCV salvage chemotherapy for recurrent primary CNS lymphoma.
Neurology 2000;54(8):1707-8.
2000: Ulrich Herrlinger; C Woiciechowski; Miguel Sena-Esteves; Karen S Aboody; Andreas H Jacobs; Nikolai G Rainov; E Y Snyder; Xandra O Breakefield
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(4):347-57.
1999: Ulrich Herrlinger
Primary CNS lymphoma: findings outside the brain.
Journal of neuro-oncology 1999;43(3):227-30.
1999: Ulrich Herrlinger; Martin Schabet; Michael Bitzer; D Petersen; Peter Krauseneck
Primary central nervous system lymphoma: from clinical presentation to diagnosis.
Journal of neuro-oncology 1999;43(3):219-26.
1999: Peter Pechan; Ulrich Herrlinger; Manish Aghi; A Jacobs; Xandra O Breakefield
Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
The journal of gene medicine 1999;1(3):176-85.
1999: Nikolai G Rainov; K Ikeda; NH Qureshi; S Grover; Ulrich Herrlinger; Peter Pechan; E Antonio Chiocca; Xandra O Breakefield; FH Barnett
Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.
Human gene therapy 1999;10(2):311-8.
1999: Nikolai G Rainov; K Ikeda; N Qureshi; S Grover; FH Barnett; Ulrich Herrlinger; Ariel Quinones; E Antonio Chiocca; Xandra O Breakefield
Intra-arterial virus and nonvirus vector-mediated gene transfer to experimental rat brain tumors.
Frontiers of radiation therapy and oncology 1999;33():227-40.
1998: Ulrich Herrlinger; Heinz Schmidberger; R Buchholz; M Wehrmann; D A Vallera; Martin Schabet
Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin.
Journal of neuro-oncology 1998;40(1):1-9.
1998: Nikolai G Rainov; Karl-Ulrich Dobberstein; Miguel Sena-Esteves; Ulrich Herrlinger; Christof M Kramm; R M Philpot; J Hilton; E Antonio Chiocca; Xandra O Breakefield
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
Human gene therapy 1998;9(9):1261-73.
1998: Ulrich Herrlinger; Christof M Kramm; KS Aboody-Guterman; JS Silver; Keiro Ikeda; KM Johnston; Peter Pechan; R F Barth; D Finkelstein; E Antonio Chiocca; David N Louis; Xandra O Breakefield
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.
Gene therapy 1998;5(6):809-19.
1998: Ulrich Herrlinger; Michael Weller; Martin Schabet
New aspects of immunotherapy of leptomeningeal metastasis.
Journal of neuro-oncology 1998;38(2-3):233-9.
1998: Martin Schabet; Ulrich Herrlinger
Animal models of leptomeningeal metastasis.
Journal of neuro-oncology 1998;38(2-3):199-205.
1998: Matthew Spear; Ulrich Herrlinger; Nikolai G Rainov; Peter Pechan; Ralph Weissleder; Xandra O Breakefield
Targeting gene therapy vectors to CNS malignancies.
Journal of neurovirology 1998;4(2):133-47.
1998: Ulrich Herrlinger; Martin Schabet; Michael Clemens; Rolf-Dieter Kortmann; D Petersen; Bernd E Will; Richard Meyermann; Johannes Dichgans
Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.
Acta neurologica Scandinavica 1998;97(4):257-64.
1997: Christof M Kramm; M Chase; Ulrich Herrlinger; A Jacobs; Peter Pechan; Nikolai G Rainov; Miguel Sena-Esteves; Manish Aghi; FH Barnett; E Antonio Chiocca; Xandra O Breakefield
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
Human gene therapy 1997;8(17):2057-68.
1997: Ulrich Herrlinger; Christof M Kramm; KM Johnston; David N Louis; D Finkelstein; G Reznikoff; Glenn Dranoff; Xandra O Breakefield; J S Yu
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
Cancer gene therapy 1997;4(6):345-52.
1997: Martin Schabet; Ulrich Herrlinger; M Weller; M Barnberg; R Clemens; J Dichgans
[New developments in diagnosis and therapy of primary non-Hodgkin's lymphoma of the central nervous system].
Der Nervenarzt 1997;68(4):298-308.
1996: Christof M Kramm; Nikolai G Rainov; Miguel Sena-Esteves; FH Barnett; M Chase; Ulrich Herrlinger; Peter Pechan; E Antonio Chiocca; Xandra O Breakefield
Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
Human gene therapy 1996;7(16):1989-94.
1996: Ulrich Herrlinger; R Buchholz; P Jachimczak; Martin Schabet
Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2.
Journal of neuro-oncology 1996;27(3):193-203.
1996: Ulrich Herrlinger; Martin Schabet; M Eichhorn; D Petersen; Ernst H Grote; Richard Meyermann; Johannes Dichgans
Prolonged corticosteroid-induced remission in primary central nervous system lymphoma: report of a case and review of the literature.
European neurology 1996;36(4):241-3.